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Abstract
Cancer progression is a complex series of events thought to incorporate the reversible developmental process of
epithelial-to-mesenchymal transition (EMT). In vitro, the microRNA-200 family maintains the epithelial phenotype
by posttranscriptionally inhibiting the E-cadherin repressors, ZEB1 and ZEB2. Here, we used in situ hybridization
and immunohistochemistry to assess expression of miR-200 and EMT biomarkers in formalin-fixed paraffin-
embedded human colorectal adenocarcinomas. In addition, laser capture microdissection and quantitative real-
time polymerase chain reaction were employed to quantify levels of miR-200 in the normal epithelium, tumor core,
invasive front, and stroma. We find that miR-200 is downregulated at the invasive front of colorectal adeno-
carcinomas that have destroyed and invaded beyond the basement membrane. However, regional lymph node
metastases and vascular carcinoma deposits show strong expression of miR-200, suggesting this family of miRNAs
is involved in the recapitulation of the primary tumor phenotype at metastatic sites. In contrast, adenomas and
adenocarcinomas with intact basement membranes showed uniform miR-200 expression from the tumor core
to the tumor-host interface. Taken together, these data support the involvement of EMT and mesenchymal-to-
epithelial transition (MET) in the metastasis cascade and show that miR-200 is downregulated in the initial stages
of stromal invasion but is restored at metastatic sites.
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Introduction
Epithelial-to-mesenchymal transition (EMT) is recognized as an
important step in invasion and metastasis, with mounting evidence
suggesting metastasis is initiated by an EMT at the invasive front of
primary carcinomas [1,2]. EMT is typified by down-regulation of
E-cadherin, reorganization of the actin cytoskeleton from a cortical to
a stress fiber distribution [3,4], and up-regulation of transcriptional
repressors, including ZEB1 and ZEB2, which bind to E-boxes in the
E-cadherin gene promoter to prevent its transcription [5]. A con-
sequence of E-cadherin down-regulation is the dissociation of adherens
junctions and the subsequent liberation of β-catenin from the plasma
membrane. Accumulation of cytosolic β-catenin can lead to its trans-
location to the nucleus where it functions in a transcription complex to
upregulate many other genes involved in migration, invasion, cell cycle
progression, and differentiation. Immunohistologic examination and
gene expression profiling of EMT biomarkers in colorectal cancer
have revealed heterogeneous expression between the tumor core and
the invasive front, indicating that a morphogenesis favoring the mesen-
chymal phenotype occurs in leading edge carcinoma cells [6–9].
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Acquisition of the mesenchymal phenotype may well assist the migra-
tion of budding tumor cells, which are defined as single cells or clusters
of up to five cells detached from the main tumor mass. Budding cells
are positively correlated with tumor relapse, lymphatic and venous
invasion, as well as lymph node, liver, and lung metastases [10–19].
Tumor budding is also associated with breakdown of the basement
membrane, a thin layer of collagenous extracellular matrix that encap-
sulates the epithelium of normal colonic crypts and adenomatous
glands. It has been shown that degradation of the basement membrane
at the invasive front of colorectal adenocarcinomas positively correlates
with metastasis and poor survival [20]. Moreover, metastases typically
resemble the differentiation state of the primary epithelial tumor, sug-
gesting that molecular changes acquired during the metastasis cascade
are reversible [6]. The reversible process of EMT provides an attractive
model for metastasis development because it describes tumor cell bud-
ding (dedifferentiation) and invasion at the primary site and redifferen-
tiation (MET) at the metastatic site [6,21]. Taken together, these
studies link EMT, budding cells, and loss of the basement membrane
to invasion and metastasis.
EMT is regulated by members of the microRNA-200 family,
which participate in a double-negative feedback loop with ZEB1
and ZEB2 [22–24]. The five members of the family are encoded
in two genes on chromosomes 1 (miR-200b∼200a∼429) and 12
(miR-200c∼141). ZEB1 and ZEB2 repress transcription of both
miR-200 genes to favor the mesenchymal phenotype, and conversely,
miR-200 family members inhibit translation of ZEB1 and ZEB2,
thereby promoting the epithelial phenotype by maintaining E-cadherin
expression. In previous quantitative real-time polymerase chain reaction
(qPCR) and immunohistochemical analyses on human ductal (epi-
thelial) and metaplastic (mesenchymal) breast cancers, we found that
ductal tumors have high levels of E-cadherin and miR-200, whereas
invasive metaplastic tumors lack both, indicating that loss of miR-200
may contribute to tumor invasion [22]. Other groups have conducted
immunohistochemistry and genetic profiling on colorectal adeno-
carcinomas, revealing that ZEB1 and ZEB2 are upregulated in leading
edge malignant cells in which nuclear β-catenin and loss of E-cadherin
are evident [7–9,20,25]. On the basis of these findings showing EMT
at the invasive front of carcinomas and the fact that the pro-invasive
properties of EMT are tightly regulated by the miR-200 family in vitro,
we considered that loss of miR-200 could be an underlying mechanism
of early invasion. We hypothesized that the miR-200 family would
be downregulated at the tumor-host interface of colorectal adeno-
carcinomas where epithelial proteins are lost and mesenchymal proteins
are gained. We show here that expression of miR-200 is down-
regulated at the invasive front of colorectal adenocarcinomas with
degraded basementmembranes and budding cells, but miR-200 expres-
sion is strong in regional metastases. Taken together, these observations
suggest that reversible EMTmediated by miR-200 contributes to colon
cancer progression.
Materials and Methods
Scratch Assay and Immunocytochemistry
Confluent SW480 cells were plated onto poly-L-lysine coated glass
slides, and a scratch was made 24 hours later using a pipette tip.
After 2 days, cells were fixed with paraformaldehyde (PFA) and per-
meabilized, and anti–E-cadherin (mouse anti–E-cadherin IgG2a,
1:500, 610182, BDTransduction Laboratories, North Ryde, Australia)
or anti-ZEB1 (E:20X, 1:50, Santa Cruz Biotechnology, Santa Cruz,
CA, sc-10572) antibodies [diluted in Triton/phosphate-buffered saline
(PBS)] were applied for 1 hour at room temperature. After three PBS
washes, secondary antibodies (Alexa Fluor goat anti-mouse IgG2a 488,
donkey anti-goat 647; Life Technologies Australia Pty Ltd, Mulgrave,
Australia), diluted in Triton/PBS, were applied to the cells for 1 hour
at room temperature in the dark. 4′,6-Diamidino-2-phenylindole
(DAPI) was added in the final 5 minutes, and then slides were washed
thrice in PBS and mounted in Dako aqueous fluorescent mounting
medium. Cells were photographed on an Olympus CellR fluores-
cence microscope.
miRNA In Situ Hybridization in Formalin-Fixed
Paraffin-Embedded Human Colon Sections
Sections of 4 μm were fixed for 10 minutes in 4% PFA (pH 9–9.9)
in PBS and then rinsed in three 5-minute PBS washes. Sections were
deproteinated for 30 minutes in Proteinase K Buffer [50 mM Tris
(pH 7.5), 5 mM EDTA, and 6.7 μg/ml Proteinase K] and then fixed
in 4% PFA for 5 minutes and washed thrice in PBS. Acetylation was
carried out for 10 minutes (30 ml of 0.1 M triethanolamine, 53.4 μl
of concentrated HCl, and 76.3 μl of acetic anhydride) before three
5-minute PBS washes. Sections were prehybridized in hybridization
buffer [50% formamide, 5× SSC (pH 4.5), 50 μg/ml yeast RNA,
1% sodium dodecyl sulfate, and 50 μg/ml heparin] in a humidified
chamber (50% formamide, 5× SSC) for 2 hours at 30°C. 3′DIG-
labeledmiRCURYLNAmiRNAprobes [snU6hsa/mmu/rno (5′ cacgaat-
ttgcgtgtcatcctt 3′, Tm= 75°C), scramble-miR (5′ ttcacaatgcgttatcggatgt 3′,
Tm=74°C), hsa–miR-200b (5′ gtcatcattaccaggcagtatta 3′,Tm=71°C), and
hsa–miR-200c (5′ ccatcattacccggcagtatta 3′, Tm = 74°C), Exiqon,
Vedbaek, Denmark] were diluted to 20 nM in hybridization buffer
and 50 μl was applied to each slide. Sections were coverslipped with
parafilm and incubated overnight in a humidified chamber at 53°C.
The next day, slides were placed in 5× SSC at 53°C and rocked for
30minutes at room temperature to remove parafilm. Stringency washes
were conducted at 53°C in 0.2× SSC for 3 hours, followed by 0.2× SSC
at room temperature for 5 minutes. Sections were washed for 5 minutes
in Buffer B1 [0.1 M Tris (pH 7.5), 0.15 M sodium chloride, and
0.24 mg/ml levamisole]. Sections were blocked for 1 hour in blocking
solution [one-fifth fetal calf serum, one-fifth 10% blocking reagent
(Roche Cat. No. 11096176001) in maleate buffer, and three-fifths
maleate buffer] and placed in a humidified chamber at room temperature.
For immunologic detection, anti-DIG antibody (Roche Diagnostics
Australia Pty Ltd, Castle Hill, Australia) was diluted to 1:5000 in the block-
ing solution. Sections were incubated in a humidified chamber at room
temperature, overnight in the dark. The next day, sections were washed
thrice in Buffer B1 and then once in Buffer B3 [0.1 M Tris (pH 9.5),
0.1M sodium chloride, 0.05Mmagnesium chloride, 0.24 mg/ml levami-
sole, and 1% Tween-20]. Buffer B4 [Buffer B3 plus 20 μl/ml nitro-blue
tetrazolium/5-bromo-4-chloro-3′-indolyphosphate (NBT/BCIP)] was ap-
plied to the sections, which were then coverslipped with parafilm. Sections
were incubated in a humidified chamber, in the dark, overnight at room
temperature. Slides were placed in tris-ethylenediaminetetraacetic acid
(TE; pH 8) for 5 minutes, with rocking, then dehydrated on a heat block
at 50°C. Slides were dipped in histolene or xylene and then mounted in a
xylene-based mounting medium. Images were captured on the Olympus
CellR or Hamamatsu Nanozoomer and analyzed using AnalySIS LS
Research software (Olympus, Australia Pty Ltd, Mt Waverley, Australia),
NDP Hamamatsu software, Microsoft Excel, and Graphpad Prism.
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Immunofluorescence
Formalin-fixed paraffin-embedded (FFPE) sections were deparaf-
finized in three 5-minute washes of histolene and then rehydrated in
two 10-minute washes of 100% ethanol, two 10-minute washes of
95% ethanol, and two 5-minute washes of MQ-H2O. Sections were
placed in PBS for 5 minutes before being immersed in 10 mM
sodium citrate buffer (pH 6.0) for 10 minutes at 95 to 99°C. Following
antigen retrieval, sections were removed from heat and allowed to
cool in the citrate buffer for 30 minutes. Sections were rinsed in three
5-minute washes of MQ-H2O and once in PBS for 5 minutes. Sections
were blocked in 1% BSA in 0.3% Triton X-100/PBS for 1 hour at
room temperature in a humidified chamber. Primary antibodies were
diluted in the blocking solution (mouse anti–β-catenin IgG1, 1:200,
BD Transduction Laboratories, 610154; mouse anti–E-cadherin
IgG2a, 1:100, BD Transduction Laboratories, 610182; mouse anti-
CK20 IgG2a, 1:50, Dako, M7019; mouse anti-AE1/AE3 IgG1,
1:400, Dako Australia Pty Ltd, Campbellfield, Australia, M3515; goat
anti-ZEB1 E:20X, 1:50, Santa Cruz Biotechnology, sc-10572). Sections
were incubated overnight at 4°C and then rinsed in three 5-minute
washes of PBS. Secondary antibodies (Alexa Fluor goat anti-mouse
IgG2a 488, goat anti-mouse IgG1 555, and donkey anti-goat 647; Life
Technologies Australia Pty Ltd) were diluted in 0.3% Triton/PBS and
applied to the sections for 2 hours in a humidified chamber in the dark.
DAPI was added in the last 5 minutes. Sections were rinsed thrice in
PBS before being mounted in Dako aqueous fluorescent mounting me-
dium. For triplicate staining, primary antibodies were applied together,
but secondary antibodies were staggered to prevent cross-reaction.
Donkey anti-goat 647 was applied for 2 hours and rinsed off, and then
goat anti-mouse 488 and 555 were applied together.
Immunohistochemistry
ZEB1 was detected with either goat anti-ZEB1 (E:20X, 1:50, Santa
Cruz Biotechnology, sc-10572) or rabbit anti-ZEB1 antiserum (1:400
fromDarling et al. [26]). Laminin was detectedwithmouse anti-laminin
(LAM-89; Sigma Immunochemicals, Sigma-Aldrich, Castle Hill,
Australia). Biotin-conjugated secondary antibodies (biotinylated anti-
goat IgG, anti-rabbit IgG, or anti-mouse IgG; Vector Laboratories,
Burlingame, CA, BA-9500) were applied (1:400), and ABC and DAB
kits (Vector Laboratories) were used to visualize expression. Sections
were counterstained with 1% methyl green.
Quantification of miRNA Staining Intensity
In situ hybridization (ISH) slides were scanned on a Hamamatsu
Nanozoomer using the ×40 objective. For each specimen, five regions
of tumor and five regions of normal epithelium were selected and
analyzed using Olympus AnalySIS software. Each region was white-
balanced, converted to grayscale, and then inverted. For each region,
10 lines were drawn from the inner to the outer part of the tumor (or
from the lumen to the muscularis mucosa in normal epithelium; see
Figure 4 for examples), and the average staining intensity along each
line was calculated and normalized to the value for the first line in the
region. The final line measured in each region was within the stroma,
where miR-200 expression was absent. For each line, values from the
five regions were then averaged and graphs of miRNA signal across the
tumor and normal epithelia were plotted in Prism, showing SEM.
Laser Capture Microdissection
FFPE sections were deparaffinized, rehydrated, and then stained
with hematoxylin and eosin (H&E). Following staining, sections were
dipped briefly in 100% ethanol, allowed to dry and then scanned on a
Hamamatsu Nanozoomer. Laser capture microdissection (LCM) was
conducted within 24 hours of H&E staining using a Zeiss PALM
LCM microscope; 105 μm2 of tissue was captured in duplicate from
areas of normal epithelium, tumor core, invasive front, and stroma
tissue. Total RNA was purified using the Qiagen miRNeasy FFPE kit
and eluted in 30 μl. Slides were coverslipped and scanned after LCM.
Multiplex Reverse Transcription, Multiplex Preamplification,
and qPCR Multiplex Primer Pool for Reverse
Transcription Reaction
Twenty-five microliters of each 5× TaqMan Reverse Transcription
(RT) primer [from Applied Biosystems kits: miR-200a (#4427975-
000502), miR-200b (#4427975-001800), miR-200c (#4427975-000505),
miR-203 (#4427975-000507), miR-205 (#4427975-000509),
miR-16 (#4427975-000391), miR-24 (#4427975-000402), miR-93
(#4427975-001090), let-7a (#4427975-000377), and RNU6
(#4427975-001093)] was pooled and then dehydrated in a SpeedVac
at 50°C. The primer pool was resuspended in 100 μl of RNase-free
H2O to give a 5× multiplex RT pool containing 62.5 nM of each
primer, which was sufficient for 50 multiplex reactions.
Reverse transcription. RT was carried out in a total volume of 10 μl
with reagents from the TaqMan MicroRNA RT Kit (Applied
Biosystems, p/n 4366597, Life Technologies Australia Pty Ltd).
Briefly, 5 μl of neat total RNA was added to 5 μl of Mastermix
(2 μl of 5× Multiplex RT primer pool, 0.2 μl of 100 mM deoxy-
nucleotide triphosphates (dNTPs), 1 μl of 50 U/μl Multiscribe reverse
transcriptase, 1 μl of 10× RT buffer, 0.125 μl of RNase inhibitor,
and 0.675 μl of RNase-free water). The reaction was mixed then iced
for 5 minutes. Conditions for the RT reaction were 30 minutes at
16°C, 30 minutes at 42°C, and 5 minutes at 85°C, followed by a
4°C soak.
Preamplification PCR of cDNA. Preamplification was conducted
according to the Applied Biosystems protocol with the exception that
all recommended reaction volumes were halved. One microliter of
each 20× TaqMan qPCR primer was combined, and the pool was
diluted by the addition of 90 μl of TE (pH 7.5) to create a 0.2×
pooled assay mix. cDNA was diluted slightly from 10 to 13 μl by
the addition of 3 μl of RNase-free water, which allowed for two
reactions, if required. Preamplification was carried out in a total vol-
ume of 25 μl, where 6.25 μl of the diluted cDNA was combined
with 12.5 μl of 2× TaqMan PreAmp Mastermix (Applied Bio-
systems, p/n 4391128) and 6.25 μl of 0.2× pooled assay mix. Cycling
parameters were 95°C for 10 minutes, followed by 14 cycles of 95°C
for 15 seconds and 60°C for 4 minutes. The preamplification prod-
ucts were placed on ice upon completion of the reaction. Preamplified
products were diluted to 1:20 in TE before qPCR.
Quantitative real-time RT-PCR of miRNA. Real-time PCRs of
individual miRNAs were conducted in a total volume of 10 μl [0.5 μl
of 20× TaqMan primer, 5 μl of 2× TaqMan Mastermix (Applied
Biosystems p/n 4364343), 2 μl of RNase-free water, and 2.5 μl of
diluted preamplified cDNA]. Real-time PCR was performed in trip-
licate on a Rotor-Gene 6000 PCR machine (Corbett Research/Qiagen,
Chadstone Centre, Australia) under the conditions of 95°C for
10 minutes, followed by 50 cycles at 95°C for 15 seconds and 60°C
for 1 minute. Data were collected and analyzed using comparative
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quantification Rotor-Gene software. MicroRNA levels for each sample
were normalized to a pool of four unchanging control miRNAs (let-7a,
miR-16, miR-24, and miR-93).
Results
An In Vitro Model Suggests Detaching Colon Cancer Cells
Undergo EMT
Up-regulation of mesenchymal proteins and repression of epi-
thelial proteins are proposed to be important molecular features
for the progression of tumor cells to an invasive phenotype. Here,
we sought to investigate in vitro whether colon cancer cells, given
the opportunity to detach from a confluent epithelial layer, ex-
hibit typical characteristics of EMT. We scratched away a strip
of cells from a confluent monolayer of SW480 colon cancer cells
to provide a space into which the cells could migrate and mon-
itored EMT changes in cells at the edge of the monolayer by
staining for the epithelial marker E-cadherin and the mesenchy-
mal marker ZEB1. At the leading edge of the scratch, epithelial
cells transformed from compact structures with round nuclei into
large, elongated, migrating cells with oval-shaped nuclei (Fig-
ure 1). Consistent with an EMT, migrating cells displayed inter-
nalization of E-cadherin and nuclear expression of ZEB1, whereas
ZEB1 was absent in confluent epithelial cells expressing membrane-
bound E-cadherin. Because ZEB1 expression is usually mutually
exclusive with miR-200 expression, this suggests that miR-200 is
downregulated in migrating cells. Noteworthy, SW480 cells are highly
plastic and on the cusp of EMT; thus, no cytokine stimulation (other
than factors already present in the medium) was required to exert
these EMT effects. Furthermore, SW480s are regarded as E-cadherin–
defective; however, this clone showed weak membranous E-cadherin,
which was internalized in cells at the leading edge. Variations in
SW480 cells have been previously reported [27,28] and this clone is
likely to be the SW480-ADH variant described by Palmer et al. [29] that
expresses E-cadherin. Taken together, the morphologic transition, loss of
membrane-bound E-cadherin, and gain of nuclear ZEB1 are indicative
of EMT contributing to the migratory and invasive characteristics of
colon cancer cells.
ISH Shows miR-200 Expression Is Lost at the Invasive Front
of Colorectal Adenocarcinomas with Degraded
Basement Membranes
If EMT contributes to cancer progression, then the miR-200 family
of microRNAs might be downregulated in invasive front regions of
adenocarcinomas. To assess this, we examined the levels of miR-200b
and miR-200c by ISH in a panel of 28 human colorectal adeno-
carcinomas that exhibited budding cells and/or other invasive prop-
erties. ISH was conducted on miR-200b and miR-200c to represent
the two miR-200 gene transcripts on chromosomes 1 (miR-200b
∼200a∼429) and 12 (miR-200c∼141). To indicate the extent to
which tumor cells had undergone EMT, we immunostained adjacent
sections for the following epithelial andmesenchymalmarkers: E-cadherin,
cytokeratins, and ZEB1. Because nuclear localization of β-catenin and
destruction of the basement membrane are further evidence of EMT,
we also immunostained sections for β-catenin and laminin, a compo-
nent of the basement membrane.
Histologic assessment of themiR-200b andmiR-200c stains revealed
strong expression in the tumor core (defined here as the bulk of the
tumor excluding the invasive front). Both miR-200b and miR-200c
were downregulated at the invasive front of adenocarcinomas in regions
showing nuclear β-catenin and loss of E-cadherin (Figure 2) and deg-
radation of the basement membrane (Figure 3). This reduction of
miR-200 intensity at the invasive front was approximately 20 cells deep
and similar in extent to the cytosolic and nuclear expression pattern of
β-catenin (Figure 2B). In addition, ZEB1, which is a posttranscrip-
tional target of the miR-200 family, was detected at the invasive front
of some cancers that showed loss of miR-200 expression and degraded
basement membranes (Figures 2, 3, W1, and W2). To verify that the
reduced ISH staining at the invasive front was specific for miR-200, we
also stained adjacent sections for the ubiquitous small nuclear RNA,
Figure 1. E-cadherin and ZEB1 expression in an in vitro model of EMT. Cultured SW480 colon adenocarcinoma cells migrating into a
scratched area were immunofluorescently stained for ZEB1 (red) and E-cadherin (green). DAPI staining is shown in blue.
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snRNA U6. There was no decrease in snRNA U6 staining at the lead-
ing edge (Figure W3). A non-targeting scrambled probe showed min-
imal background (Figure W3). As an internal control for miR-200
staining, we measured the miR-200 stain intensity across normal epi-
thelial colonic crypts matched to each adenocarcinoma specimen. The
intensity of miR-200 in normal crypts was maintained from the base
of the crypt to the lumen (Figure W3).
In contrast to the pattern of staining seen across the invasive front
of adenocarcinomas with a degraded basement membrane, adenomas
and adenocarcinomas with intact basement membranes showed no
loss of miR-200 staining intensity at the tumor-host interface, no
nuclear β-catenin, and no evidence of ZEB1 expression in tumor cells
(Figures 2D and 3).
To quantitate the miR-200 ISH staining, we performed image
analysis to measure staining intensity from the tumor core to the
tumor margin and comparing this to changes in the miR-200 inten-
sity across normal epithelium (Figure 4). In adenocarcinomas dis-
playing extensive degradation of the basement membrane, there
Figure 2. MicroRNA-200 expression is reduced at the invasive front of colorectal cancer where EMT is evident. ISH of miR-200b and
miR-200c was performed on FFPE human colorectal adenocarcinomas. Adjacent sections were immunohistochemically stained for
cytokeratins (AE1/AE3) and EMT markers, including E-cadherin, β-catenin, and ZEB1. (A) Panel of consecutive serial sections stained
with H&E; E-cadherin (green), AE1/AE3 (red), and DAPI (blue); miR-200b; and ZEB1 counterstained with methyl green. (B) Adjacent
sections of an adenocarcinoma with a degraded basement membrane stained for β-catenin and miR-200b. (C) H&E, miR-200c, and
ZEB1 at the invasive front of an adenocarcinoma with a degraded basement membrane. Arrows indicate ZEB1 expression. (D) β-catenin,
miR-200c, and ZEB1 in an adenocarcinoma with an intact basement membrane. Scale bars represent 100 μm. This staining pattern was
representative of 10 tumors examined in this way.
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was significant reduction in miR-200 staining intensity at the inva-
sive edge (example shown in Figure 4, A–C ). In contrast, adenomas
and adenocarcinomas with intact basement membranes showed uni-
form expression of miR-200 from the tumor core to the tumor-host
interface (Figure 4, D–F ). In summary, histologic analysis of miR-200
expression in colorectal tumors revealed a decreasing gradient of expres-
sion toward the invasive front of adenocarcinomas that showed evi-
dence of EMT and degradation of the basement membrane. In
contrast, miR-200 expression was maintained in adenomas and adeno-
carcinomas that showed no signs of EMT and had not invaded beyond
the basement membrane.
qPCR of miR-200 from Laser Capture
Microdissected Adenocarcinomas
To further verify that the reduced miR-200 staining at the invasive
front is due to lower levels of the miRNAs, we microdissected a series
of adenocarcinomas by laser capture microscopy (Figure W4) and
measured the miRNA levels by qPCR with multiplex preamplifica-
tion. We quantified miRNA levels in normal colonic crypts, the tumor
core, and the invasive front, as well as nearby stromal tissue. The
expression levels of nine microRNAs (miR-200a, miR-200b, miR-200c,
miR-203, miR-205, miR-24, miR-16, miR-93, and let-7a) and snRNA
U6 were measured and normalized to a pool of controls (miR-16,
miR-24, miR-93, and let-7a). Figure 5 shows the qPCR data from
the same representative tumors shown in Figure 4. Concordant with
the ISH data, qPCR revealed that miR-200 expression was down-
regulated in malignant cells at the invasive front of the adenocarci-
noma with a degraded basement membrane (Figure 5A), whereas
the adenocarcinoma with an intact basement membrane showed
no loss of miR-200 at the tumor-host interface by qPCR (Figure 5B).
We also measured miR-205 and miR-203, which are downregulated
during EMT in vitro [22,35]. However, expression of miR-205 and
Figure 3. Loss of miR-200 is associated with up-regulation of ZEB1 and degradation of the basement membrane. Comparison of ZEB1,
miR-200b, and basement membrane status in two primary adenocarcinomas. Serial sections showH&E, ZEB1 andmethyl green, miR-200b,
and laminin and methyl green in an adenocarcinoma with an intact basement membrane (left panels) and in an adenocarcinoma with a
degraded basement membrane (right panels). Arrows indicate regions of basement membrane degradation. Scale bars represent 100 μm.
These images are representative of seven tumors examined.
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Figure 4. Quantification of ISH intensity. Representative results from adenocarcinomas with degraded (A–C) and intact (D–F) basement
membranes. (A) ISH for miR-200c of a moderately differentiated pT3N0 adenocarcinoma with budding cells and degradation of the
basement membrane at the tumor-host interface. (B, E) Representative examples of analyzed regions (inverted images and heat maps)
of normal (blue) and tumor (pink) epithelia. Each region was white-balanced, converted to grayscale, and then inverted before the intensity
of themiR-200 signal wasmeasured across five regions (one region is shown) of normal and tumor epithelia. In each region, 10 lines were
drawn to produce histograms of gray values, which were then averaged across the five regions (±SD). (C, F) Quantification of the miR-200
stain. Intensity values were measured from the lumen to the base of the crypt in normal epithelium and from the core to the invasive front
of tumor epithelium. The final measurement was taken from the stroma. Data were normalized to the first point in normal and tumor
regions (±SD). (D) Quantification of miR-200b staining across a well/moderately differentiated pT1N1 adenocarcinoma. This tumor was
confined to the submucosa, displayed strong borders at the tumor-host interface, and had invaded into an adjacent blood vessel (arrow).
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miR-203 in laser microdissected colorectal tissue was at the lower
limit of qPCR detection and no significant difference in expression
between the four tissue areas was found. Pooling the qPCR data from
six adenocarcinomas with degraded basement membranes revealed a
significant reduction in miR-200b and miR-200c expression at the
invasive front compared to the tumor core and normal epithelium
(Figure 6A). These data were consistent with the pooled ISH data
showing loss of miR-200b and miR-200c expression toward the inva-
sive front (Figure 6, B and C). Additionally, miR-200a showed a trend
toward reduction at the invasive front by qPCR but did not reach
statistical significance (Figure 6A). Interestingly, qPCR revealed that
some tumors that did not display differential expression of miR-200a
and/or miR-200b between the tumor core and the invasive front
already had reduced miR-200a and/or miR-200b in the tumor com-
pared to normal epithelium (Table W1).
miR-200 Is Expressed in Regional Lymph Node Metastases and
Vascular Lesions
Among the 28 specimens analyzed by ISH in this study, five dis-
played regional lymph node metastases or vascular deposits proximal
enough to be present on the primary adenocarcinoma section. One
example each of lymph node and vascular lesions is shown in Fig-
ure 7. Histologic assessment revealed intense miR-200 staining in
these malignant lesions, despite a decline of miR-200 toward the
invasive front of the primary adenocarcinoma (Figure 7). This is con-
sistent with the notion that metastasis occurs through a cascade of
events involving dedifferentiation (EMT) at the primary tumor site
and redifferentiation (MET) at the secondary site [6,21]. Consistent
with a reversion to the epithelial phenotype at the secondary site, the
lymph node metastases and vascular lesions arising from primary
adenocarcinomas expressed E-cadherin and β-catenin at the cell
Figure 5. qPCR confirms that expression of miR-200 is downregulated at the invasive front of adenocarcinomas with degraded
basement membranes and maintained in tumors with intact borders. Multiplex qPCR of miRNAs from duplicate regions of normal
(N), tumor (T), invasive front (IF), and stroma (S). (A) Data correspond to the specimen shown in Figure 4A, which had a degraded
basement membrane and loss of miR-200 at the invasive front indicated by ISH. Asterisks represent significant loss (P < .05) of
miR-200 at the invasive front compared to both normal and tumor core epithelial tissues. (B) Data correspond to the specimen
shown in Figure 4B, which had an intact basement membrane and uniform expression of miR-200 from the tumor core to the
invasive front by ISH. All miRNAs were normalized to a pool of control miRNAs that are unchanged during EMT (miR-16, 24, 93,
and let-7a).
Neoplasia Vol. 15, No. 2, 2013 miR-200 Loss at Colon Cancer Invasive Front Paterson et al. 187
membrane and stained positively for the pan-cytokeratin antibody
AE1/AE3, as well as cytokeratin-20 (CK-20), and miR-200 (Fig-
ure 7). These results show that the miR-200 family is expressed in
metastases and collectively, with the ISH and qPCR data showing
loss of miR-200 at the invasive front of primary adenocarcinomas,
add further support to the concept that EMT involving down-
regulation of miR-200 promotes local invasion, but up-regulation of
miR-200 and MET occur at distant sites of metastatic growth.
Figure 6. Pooled data show a statistically significant reduction in miR-200 expression at the invasive front of adenocarcinomas with
degraded basement membranes. (A) qPCR analysis of laser microdissected epithelium from normal crypts, the tumor core, and the
invasive front of six adenocarcinomas with degraded basement membranes. For each specimen and region, two separate laser micro-
dissection samples were captured and separately analyzed. These are represented separately by black and white dots. A linear mixed
effects model was used to compare expression of miR-200a, miR-200b, and miR-200c. (B) ISH data pooled from 10 to 13 adenocarci-
nomas with degraded basement membranes. (C) Pooled ISH data from three to five adenomas and adenocarcinomas with intact base-
ment membranes. Error bars in B and C represent SEM.
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Discussion
In this study, we explored the role of miR-200 in the progression of
colorectal cancer. On the basis of the notion that invasion of leading
edge cells through the basement membrane occurs as a direct result
of EMT and that down-regulation of miR-200 is an essential com-
ponent of EMT in vitro, we predicted that miR-200 would be down-
regulated in malignant cells undergoing EMT at the tumor-host
interface. This was observed in 18 of 18 adenocarcinomas with de-
graded basement membranes that had a sufficient in situ signal to
quantify (Table W1). Given miR-200 is a potent regulator of EMT,
its loss at the invasive front of carcinomas further supports the concept
that EMT underlies tumor invasion.
Figure 7. miR-200 expression in lymph node metastases and vascular lesions. (A) A diffuse adenocarcinoma with a lymph node metas-
tasis. Adjacent sections immunostained for cytokeratins (AE1/AE3) and EMT markers, including E-cadherin miR-200. (Top) Panel of con-
secutive serial sections stained with H&E, miR-200b, and for the pan-cytokeratin antibody AE1/AE3 (counterstained with hematoxylin;
scale bars represent 1 mm). (Middle) Magnified images of the lymph node metastasis (scale bars represent 100 μm). (Lower) Merged
and separate images of the lymph node immunostained with AE1/AE3 antibody (red) and E-cadherin (green). (B) Adenocarcinoma with
malignant lesions in a proximal blood vessel. Adjacent sections stained with H&E (top), miR-200b (center, right), and CK-20 (green) and
β-catenin (red).
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Our ISH and qPCR analyses showed that expression of miR-200b
and miR-200c declines toward the invasive front of adenocarcinomas
displaying budding cells. Most importantly, the invasive margins of
these tumors lacked the strong boundaries provided by an intact
basement membrane. This finding complements the work of Spaderna
et al. [20], who demonstrated that loss of the basement membrane in
colorectal adenocarcinomas correlates with metastasis and poor survival.
In addition, they showed that ZEB1 is upregulated in invasive front
regions deficient of a basement membrane and that ZEB1 directly re-
presses transcription of LAMA3, which encodes an essential basement
membrane protein. Here, we demonstrate that down-regulation of
miR-200 is also associated with expression of ZEB1 and degradation
of the basement membrane at the invasive front of colorectal adeno-
carcinomas. Furthermore, these findings are consistent with the miR-
200 family participating in a double-negative feedback loop with
ZEB1 [23,24].
Our results indicate that the altered expression patterns of miR-200
and β-catenin occur to a similar degree in cells at the invasive front
(Figure 2B). Specifically, the depth of the declining gradient of miR-
200 toward the leading edge was similar in extent to the expression
pattern of β-catenin, which shifted from membrane-associated in the
tumor core to cytoplasmic and nuclear localization at the invasive front.
Noteworthy, Xia et al. [30] reported that β-catenin mRNA is a target of
miR-200a; therefore, loss of miR-200a expression in leading edge cells
could directly contribute to the accumulation of cytosolic and nuclear
β-catenin. Interestingly, the neural cell adhesion marker L1-CAM,
whose expression is generally confined to nerve cells, has been found to
be upregulated at the invasive front of colorectal cancer [31]. L1-CAM is a
β-catenin target gene, a promoter of cell motility, and is positively cor-
related with metastasis [32]. It is not expressed in the tumor core or
normal epithelium, nor is it a predicted target for the miR-200 family;
however, it does show a remarkable inverse expression pattern to miR-
200 in colorectal cancer [31–33].
While in vitro EMT models in carcinoma cell lines demonstrate
that reduced miR-200 expression promotes invasion and migration
[22,30], investigations in vivo have shown the miR-200 family can
encourage or minimize metastasis in mouse models of breast, lung,
and pancreatic cancers [34–36]. Collectively, these studies indicate
that constitutive overexpression of miR-200 is protective against inva-
sion and metastasis (e.g., [34]), yet that miR-200 is required for metas-
tasis [36]. On the basis of our data 1) showing loss of miR-200 by ISH
and qPCR at the invasive front of advanced primary colorectal adeno-
carcinomas lacking intact basement membranes and 2) revealing strong
expression of miR-200 in local metastases, we postulate that high
expression of miR-200 in the primary tumor favors metastasis forma-
tion, provided the cells at the invasive front can undergo EMT, and that
these budding mesenchymal cells retain the ability to switch from the
mesenchymal state back to the epithelial state to favor colonization in a
foreign microenvironment. Our data are consistent with the work of
Korpal et al. [37], who demonstrated a pro-metastatic role for miR-
200. They found that increased miR-200 in human breast cancers cor-
related with poor distant disease-free survival and, most remarkably,
showed that in a mouse model of breast cancer metastasis, elevated
miR-200 in primary mammary tissues favoredmetastasis, despite inhib-
iting invasion and intravasation into the blood at the primary carcinoma
site. They postulated that the miR-200 family is able to minimize inva-
sion by inhibiting EMT, but if these malignant cells do intravasate into
the blood, they have an increased propensity to colonize at distant sites
due to their highly epithelial origin. More recently, Hur et al. [38]
showed that miR-200c is downregulated at the invasive front of
colorectal cancer and upregulated in liver metastasis. Here, we showed
that miR-200b is also downregulated at the invasive front. Taken
together, our findings and those of Korpal et al. [37] and Hur et al.
[38] indicate that altered expression of the miR-200 family contributes
to poor outcome.
In summary, this study complements a large volume of work on
expression of EMT markers at the invasive front of colorectal adeno-
carcinomas and further implicates the miR-200 family, a strong reg-
ulator of EMT and MET, in invasion and metastasis. With an aging
population, rising levels of obesity, and poor dietary and lifestyle
habits, the incidence of colorectal cancer is likely to increase; there-
fore, we must look to novel targets to treat this disease. The metas-
tasis cascade consists of a broad range of molecules that anticancer
therapies could potentially target to prevent invasion (EMT) and
metastasis (MET). Moreover, the ZEB–miR-200 axis holds much
potential as an anticancer target because of its ability to regulate
migratory cancer stem cells.
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Figure W1.MicroRNA-200 expression is reduced at the invasive front of colorectal cancers with degraded basement membranes. ISH of
miR-200b and miR-200c was performed on FFPE human colorectal adenocarcinomas. Adjacent sections were immunohistochemically
stained for laminin and ZEB1. (A) Consecutive serial sections of an adenocarcinoma with a degraded basement membrane stained with
H&E (top), miR-200c (middle), and laminin counterstained with methyl green (bottom). (B) H&E, miR-200b, ZEB1, and laminin at the
invasive front of an adenocarcinoma with a degraded basement membrane. Scale bars represent 100 μm.
Figure W2. MicroRNA-200 expression is reduced at the invasive front of colorectal cancer where ZEB1 is upregulated. (A) Adjacent
sections of an adenocarcinoma with a degraded basement membrane stained for miR-200c and ZEB1 (counterstained with methyl
green). (B) Examples of ZEB1 expression in adenocarcinomas with degraded basement membranes (counterstained with methyl green).
Arrows indicate ZEB1 expression. Scale bars represent 100 μm.
Figure W3. Positive and negative controls for ISH. Normal and tumor colon tissues stained through ISH with 3′DIG-labeled LNA probes
for a negative scrambled control, the ubiquitous small nuclear RNA U6 (positive control), miR-200b, and miR-200c. Arrows point to the
invasive front. Scale bars represent 100 μm.
Figure W4. Examples of laser microdissected regions. Images of normal, tumor, invasive front, and stromal regions taken before LCM
(left column) and after LCM (right column). Two 0.1-mm2 samples were captured from each region and separately column-purified for
miRNA. Arrows point to microdissected leading edge regions in tumors with intact and degraded basement membranes. The stroma
image demonstrates the amount of tissue required per region. Scale bars represent 100 μm.
Table W1. Summary of miR-200 ISH and qPCR Data from Colorectal Cancers.
TNM Status Defining Morphologic
Features









in the Tumor Compared
to Normal Crypts
a b c a b c
pT3N0M0 Budding cells, loss of basement membrane
at leading edge, tubular invasion poles
Loss Absent ↓ ↓ ↓ – – –
pT3N0M0 Present – – ↓ ↓ ↓ –
pT4aN2M0 Present – ↓ ↓ ↓ – –
pT4aN0M0 Present ↓ ↓ ↓ – – –
pT4aN0M0 Present – ↓ ↓ – – –













pT1N1M0 No budding cells, intact basement membrane,
smooth tumor-host interface
No loss Present – – – – – –





pT4bN1M0 Too weak to detect Present – – ↓ – – –
pT4bNXMX Present – – – – ↓ ↓
pT3N2bMX Present
pT1N1bM0 Present
Comparison of morphologic features common to adenocarcinomas with either loss or maintenance of miR-200 at the tumor-host interface. Pathologic assessment of Tumor-Node-Metastasis (TNM)
status shown in column 3. Column 4 summarizes the ISH results. Quantitative real-time RT-PCR comparison between the tumor and invasive front and between tumor and normal epithelia is shown in
columns 5 and 6, respectively (arrow denotes loss of miR-200 expression, and dash denotes no loss).
